Another study also constructed a ceRNA network related to HCC recurrence, and revealed that four mRNAs (ADH4, DNASE1L3, HGFAC and MELK) could be used as potential biomarkers for HCC recurrence prediction and targeted therapies [12]. The gene discussed is DNASE1L3; the disease is hepatocellular carcinoma.